Pregnancy, childbirth, postpartum, and infant health updates and guidance.
CDC says to stop using a recalled Nara Organics powdered infant formula if your baby may have had it, and to watch for infant botulism warning signs for up to a month after last use. Get emergency care right away if you notice feeding/swallowing changes, decreased facial expression, or head control weakness.
CDC says listeriosis symptoms can start soon after exposure—but they may also be delayed. If you ate recalled soft ricotta/requesón while pregnant, here’s what to watch for and what to do next.
ACOG’s pregnancy vaccine schedule and CDC’s vaccine-table view can look mismatched at first glance—especially for COVID-19. Here’s how to use ACOG for the “what to plan,” then use CDC’s dedicated pregnancy pages to confirm the timing logic for RSV (Abrysvo) and COVID-19.
New June 2026 data support maternal RSV vaccination, but CDC’s main rule has not changed: most babies should be protected by either the pregnancy shot or a long-acting RSV antibody after birth, not both.
ACOG’s June 2026 pregnancy vaccine schedule still includes COVID-19, while current CDC and HHS language is narrower. Here’s the practical difference for timing, access, and coverage.
FDA says all lots of Nara Organics infant formula currently on the market are recalled after a June 2026 infant botulism investigation. Here is what parents should do now, which symptoms need emergency care, and what is still unknown.
Federal officials are investigating a June 13, 2026 recall of Nara Organics infant formula after three confirmed or suspected infant botulism illnesses. Here is what parents should do now, which symptoms need emergency care, and what remains uncertain.
A federal testing update on April 29, 2026 was broadly reassuring for the U.S. infant formula market. But a May 2 recall of three a2 Platinum lots still means parents should check batch numbers, stop only recalled tins, and call a pediatrician if vomiting develops.
There are two main ways to help protect babies from severe RSV: maternal vaccination during a narrow pregnancy window, or an infant RSV monoclonal antibody after birth. CDC says the right option depends on timing, eligibility, and whether a mother already received RSV vaccine in a previous pregnancy.
The FDA has issued new guidance aimed at improving how pregnancy safety data are collected for drugs and biologics. For patients, the practical takeaway is not that treatment rules changed today, but that the evidence base for medicine use in pregnancy may become more useful over time.
The FDA has finalized new guidance on collecting pregnancy-safety data after a drug or biologic is approved. The change will not rewrite labels overnight, but it could strengthen the evidence doctors and patients rely on when deciding whether medicine is needed during pregnancy.
CDC’s latest coverage dashboard shows that many pregnant people still have not chosen an RSV prevention strategy. The practical question is still timing: maternal Abrysvo in late pregnancy or infant nirsevimab after birth.
CDC and ACOG say families now have two main ways to protect babies from RSV: maternal vaccination during the right pregnancy window or an antibody product for the infant. New CDC surveillance suggests many babies still miss protection, often when clinicians do not clearly recommend it.
CDC’s latest measles update has many parents asking about babies under 12 months. Here’s when an early MMR dose may be advised and what to do after exposure.
Measles cases are climbing. Here’s when babies 6 to 11 months may get an early MMR shot, why it does not replace routine doses, and what parents should do.
A federal import plan may ease some Bicillin L-A shortages, but access can still vary. For pregnancy, penicillin remains the only recommended syphilis treatment.
Postpartum mental-health support is stretching across the full first year after birth, with longer Medicaid coverage, more screening chances, and a federal hotline.
Whooping cough stayed elevated in the U.S. in 2025. Here’s what that means for family vaccines, test timing, and why clinics want suspected cases to call first.
After the ByHeart-linked infant botulism outbreak, the FDA says it is tightening recall follow-through, making formula information easier for families to find, and expanding sampling and surveillance. Here is what changed, what parents should watch for, and what is still not fully known.
Federal officials say the ByHeart-linked infant botulism outbreak is over, but all ByHeart Whole Nutrition infant formula remains recalled. Here’s what parents should do now, which symptoms need urgent care, and what is still unknown.
As of February 2026, CDC estimated that 65.1% of U.S. infants born since April 1, 2025 were already protected against RSV through maternal immunization only or an infant monoclonal antibody, with another 9.1% of parents saying they definitely planned to get the infant product. For most babies, protection comes from one route or the other, not both. ([cdc.gov](https://www.cdc.gov/rsvvaxview/dashboard/index.html))
The CDC has released its 2026 U.S. immunization schedules. Here’s what changed, how to read the color‑coded tables, who should review their records, and what the updates mean for insurance coverage, schools, and preventive care.
End of content
End of content
